EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effects of Benzalkonium Chloride, a Preservative in Topical Drugs, on the Barrier Function of Human Corneal Epithelial Cells

Xiang Zheng, Mohamed Shawky, Diego G Ogando, Miho Nishiyama, Ahmed S Ibrahim, Sangly P Srinivas

Translational Vision Science & Technology · 14.11.2025 · 14 (11) · 16

DOI: 10.1167/tvst.14.11.16 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Vision Science & Technology, erschienen am 14.11.2025. Verfasst von Xiang Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Optometry, Indiana University, Bloomington, IN, USA. Hauptthemen laut MEDLINE: Benzalkonium Compounds, Preservatives, Pharmaceutical, Epithelium, Corneal, Epithelial Cells. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To assess the influence of varying concentrations of benzalkonium chloride (BAK), the predominant preservative utilized in ophthalmic formulations, on the barrier integrity and mitochondrial function of primary cultured human corneal epithelial cells (HCECs).

Methods

Primary HCEC monolayers were exposed to BAK at concentrations ranging from 0.02% to 0.00002%. The barrier function was monitored using electric cell-substrate impedance sensing (ECIS), where a decrease in electrical resistance signified a loss of barrier function. Mitochondrial function was evaluated after 24 hours of BAK exposure with the Seahorse XFe96 Flux Analyzer, which measured basal respiration, adenosine triphosphate (ATP) production, and maximal respiration.

Results

High BAK concentrations (≥0.02%) caused a rapid, dose-dependent decrease in resistance, exceeding 40% within 1 hour. In contrast, lower concentrations (0.00025%-0.002%) led to a delayed, gradual reduction. Specifically, 0.00025% BAK resulted in a 37% decrease in resistance by 72 hours, whereas 0.0001% caused a 26% reduction; concentrations ≤ 0.00005% had no significant effect. Increased capacitance accompanied the resistance loss, indicating membrane disturbance. Seahorse analysis revealed that BAK concentrations ≥ 0.00005% significantly reduced basal respiration and ATP production. Maximal respiration decreased at higher doses (≥0.0001%).

Conclusions

BAK induces concentration-dependent, cumulative toxicity in HCECs, causing rapid membrane disruption and irreversible barrier failure at or above its critical micelle concentration (CMC), along with ongoing sub-CMC toxicity through mitochondrial suppression at lower doses. These findings highlight the need for preservative strategies that reduce both acute and chronic epithelial damage in ophthalmic applications. Translational Relevance: Real-time impedance and mitochondrial assessments determine thresholds for BAK toxicity, guiding the development of safer ophthalmic formulations to protect the ocular surface.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzalkonium CompoundsPreservatives, PharmaceuticalEpithelium, CornealEpithelial CellsHumansCells, CulturedMitochondriaAdenosine TriphosphateElectric Impedance

Substanzen

Benzalkonium CompoundsPreservatives, PharmaceuticalAdenosine Triphosphate

Autor:innen und Institutionen

  • School of Optometry, Indiana University, Bloomington, IN, USA.
  • Department of Ophthalmology, Visual, and Anatomical Sciences, Wayne State University, Detroit, MI, USA.
  • Department of Biochemistry, Faculty of Pharmacy, Horus University, New Damietta City, Egypt.
  • ROHTO Pharmaceutical Co. Ltd., Osaka, Japan.
  • Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
  • Department of Pharmacology, Wayne State University, Detroit, MI, USA.

Förderung

  • NEI NIH HHS

Zitieren

APA

Zheng, X., Shawky, M., Ogando, D. G., Nishiyama, M., Ibrahim, A. S., & Srinivas, S. P. (2025). Effects of Benzalkonium Chloride, a Preservative in Topical Drugs, on the Barrier Function of Human Corneal Epithelial Cells. Translational Vision Science & Technology, 14(11), 16. https://doi.org/10.1167/tvst.14.11.16

Vancouver

Zheng X, Shawky M, Ogando DG, Nishiyama M, Ibrahim AS, Srinivas SP. Effects of Benzalkonium Chloride, a Preservative in Topical Drugs, on the Barrier Function of Human Corneal Epithelial Cells. Translational Vision Science & Technology. 2025;14(11):16. doi:10.1167/tvst.14.11.16

BibTeX
@article{Zheng2025,
  author = {Zheng, Xiang and Shawky, Mohamed and Ogando, Diego G and Nishiyama, Miho and Ibrahim, Ahmed S and Srinivas, Sangly P},
  title = {Effects of Benzalkonium Chloride, a Preservative in Topical Drugs, on the Barrier Function of Human Corneal Epithelial Cells},
  journal = {Translational Vision Science & Technology},
  year = {2025},
  volume = {14},
  number = {11},
  pages = {16},
  doi = {10.1167/tvst.14.11.16}
}
Kostenlos starten →